Overview

Safety and Efficacy Study of YZJ-1139 in Insomnia Disorder

Status:
Recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to assess efficacy and safety of YZJ-1139 in adult subjects with insomnia disorder. Efficacy will be evaluated on objective and subjective sleep parameters.
Phase:
Phase 3
Details
Lead Sponsor:
Shanghai Haiyan Pharmaceutical Technology Co., Ltd.